Reason: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the proposed interim limit.
Distributed: Nationwide in the U.S.Reason: Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C
Distributed: US Nationwide.Reason: Discoloration: Brownish tablets
Distributed: MIReason: Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Distributed: US Nationwide and Puerto Rico.Reason: Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Distributed: US Nationwide and Puerto Rico.Reason: Presence of Foreign Substance; Broken metal piece found embedded in tablet.
Distributed: U.S. NationwideReason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Distributed: Nationwide in the USAReason: Subpotent Drug
Distributed: Nationwide within the United StatesReason: Labeling: Label Mix up; product labeled as pure white petroleum jelly actually contains petroleum jelly with Lavendar and Chamomile
Distributed: Nationwide.Reason: Failed Content Uniformity Specifications
Distributed: Nationwide in the US